Catalyst Pharmaceuticals (CPRX) Tops Q1 EPS by 9c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.44 +0.03%
EPS Growth %: -30.9%
Financial Fact:
Loss per share - basic and diluted: -0.05
Today's EPS Names:
CRMT, FOMI, FLES, More
EPS Growth %: -30.9%
Financial Fact:
Loss per share - basic and diluted: -0.05
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q1 EPS of $0.41, $0.09 better than the analyst estimate of $0.32. Revenue for the quarter came in at $85.4 million versus the consensus estimate of $81.62 million.
GUIDANCE:
Catalyst Pharmaceuticals sees FY2023 revenue of $195-205 million, versus the consensus of $165.8 million.
For earnings history and earnings-related data on Catalyst Pharmaceuticals (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- American Eagle Outfitters names new CFO, reaffirms 2026 guidance
- Innovex closes $95M acquisition of TCO Group AS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
